Topics

Genea Stem Cells Pty Ltd Company Profile

21:34 EST 22nd January 2020 | BioPortfolio

Genea Stem Cells Pty Ltd is a subsidiary of Genea Limited (formerly Sydney IVF Limited), a public, unlisted company that has been operating IVF clinics in Australia since 1985. Genea Stem Cells Pty Ltd is governed by the same strong ethical principles and corporate governance practices.

Genea Stem Cells is located in Sydney, Australia and has been supplying commercial stem cell solutions for several years, drawing on an almost 30 year research heritage within Genea.

Genea Stem Cells supplies and develops disease-specific pluripotent and differentiated human embryonic stem cells for use in drug development and research.Our Company’s cellular products are genetically unmodified human cells - the most accurate in vitro reflection of clinical conditions, promising more predictive disease models and thereby reducing the need for animal studies. GSC provides the following products for use in drug development and medical research:

  • The world’s largest private bank of pluripotent human embryonic stem cells. More than 100 cell lines representing almost 30 genetic diseases and a variety of genetic backgrounds. These cell lines are derived in full compliance with international ethical and regulatory guidelines.
  • The world’s only commercially-available, application-ready differentiated disease specific cell types (available from any GSC stem cell line).
  • A unique specialised stem cell medium  (Genea M2) – serum-free, fully-defined and applicable for high throughput screening applications.

As well as providing the above products, we also work collaboratively with industry for custom-developed cell-based assay solutions in drug development.

Stem cell lines derived at Genea Stem Cells are derived from excess ART embryos and those unsuitable for further clinical use. These embryos are excess to the clinical requirements of Genea patients and have been specifically donated for stem cell derivation. Embryo donation for research purposes is subject to strict ethical and regulatory mechanisms. Consent is voluntary, fully informed and offered to couples as an option.

 

Location

Level 3, 321 Kent Street
Sydney,
New South Wales
2000
AUSTRALIA

Contact

Phone: +61 2 8484 7662
Fax: +61 2 9229 6478
Email: genea.stemcells@genea.com.au


News Articles [2201 Associated News Articles listed on BioPortfolio]

T Cells Infiltrate the Aging Brain

As published in a recent study, researchers have discovered that neural

Differentiating Stem Cells into Heart Muscle

A recent review shows the current state of t

Purifying Stem Cell Therapies with Suicide Genes

A new study recently accep

LifeXtenShow – Stem Cells With Naz

On this talk episode of X10, Nazli Eskici of the University of Helsinki discusses

Addition of growth factors to unique system helps new bone formation

The development of new bone can be a multistep process: first, stem cells differentiate into cartilage cells. Next, the cartilage cells become bone cells. But that's not all: the cells must experience...

First events in stem cells becoming specialized cells needed for organ development

(University of Toronto) Cell biologists at the University of Toronto shed light on the very first step stem cells go through to turn into the specialized cells that make up organs. The findings publis...

Artificial muscle sheets transform stem cells into bone

Specifically programmed materials can, under specific conditions, encourage stem cells to transform into bone cells. To do this, scientists implemented a so-called shape-memory polymer in stem cell re...

Expanded Potential Stem Cells of Both Pig and Human Cells Created

Scientists have been able to, for the first time ,derive stem cells from early pig embryos. The research team's work offers great potential for studying human development and regenerative medicine. Th...

Drugs and Medications [32 Associated Drugs and Medications listed on BioPortfolio]

Iv busulfex(busulfan) injection [esp pharma, inc.]

IV Busulfex(busulfan) Injection

Methylphenidate hydrochloride [corepharma, llc]

Methylphenidate Hydrochloride Tablets, USP5 mg, 10 mg and 20 mgCIIRx only

Methylphenidate hydrochloride [impax generics]

Methylphenidate Hydrochloride Tablets, USP5 mg, 10 mg and 20 mgCIIRx only

Methylphenidate hydrochloride [kvk-tech, inc.]

Methylphenidate Hydrochloride Tablets USP CII Rx only Prescribing Information

Methylphenidate hydrochloride [alvogen inc.]

Methylphenidate Hydrochloride Extended-Release Tablets USP, CII                         

PubMed Articles [5117 Associated PubMed Articles listed on BioPortfolio]

The RUNX1 Enhancer Element eR1: A Versatile Marker for Adult Stem Cells.

The identification of adult stem cells is challenging because of the heterogeneity and plasticity of stem cells in different organs. Within the same tissue, stem cells may be highly proliferative, or ...

Concise Review: Targeting multiple cell surface receptors in tumors with engineered stem cells.

Multiple stem cell types exhibit inherent tropism for cancer, and engineered stem cells have been used as therapeutic agents to specifically target cancer cells. Recently, stem cells have been enginee...

Mutualism in the Marrow.

Cross-talk between hematopoietic stem cells (HSCs) and the HSC niche is likely important in hematopoiesis but not well demonstrated. Now in Cell Stem Cell, Chen et al. (2019) describe how specialized...

Mesenchymal stem cells preserve their stem cell traits after exposure to antimetabolite chemotherapy.

Mesenchymal stem cells (MSCs) participate in the regeneration of tissue lesions induced by antimetabolite chemotherapy; however, the influence of this class of anti-cancer compounds on the stem cells ...

Heterogeneity of Stem Cells in the Hippocampus.

The discovery of neural stem cells in the adult mammalian hippocampus has attracted attention and controversy, which both continue to this day. Hippocampal neural stem cells and their immediate progen...

Clinical Trials [9560 Associated Clinical Trials listed on BioPortfolio]

Safety and Tolerability Study of Allogeneic Mesenchymal Stem Cell Infusion in Adults With Cystic Fibrosis

This study is being done to test if it is safe to give stem cells to adult patients with Cystic Fibrosis (CF). The kind of stem cells we are studying are called allogeneic human mesenchyma...

Dysfunctions of Human Muscle Stem Cells in Sepsis

The dysfunction of muscle stem cells after sepsis is demonstrated in mice. It is also observed that mesenchymal stem cells have a positive effect on muscle stem cells in this animal model....

HIV-Resistant Gene Modified Stem Cells and Chemotherapy in Treating Patients With Lymphoma With HIV Infection

This pilot phase I trial studies the side effects and best dose of human immunodeficiency virus (HIV)-resistant gene modified stem cells in treating HIV-positive patients who are undergoin...

Thalassemia Treatment Based on the Stem Cell Technology

In order to study the transplantation effect of hematopoetic stem cells from beta-thalassemia induced pluripotent stem cells. We applied clinical grade source of autologous hematopoietic s...

Endocardial Stem Cells Approach Efficacy

The primary objective of this study is to test that endocardial stem cells implantation in patients who have CAD, low ejection fraction and signs of HF without possibility of CABG and PCI ...

Companies [884 Associated Companies listed on BioPortfolio]

Genea Stem Cells Pty Ltd

Genea Stem Cells Pty Ltd is a subsidiary of Genea Limited (formerly Sydney IVF Limited), a public, unlisted company that has been operating IVF clinics in Australia since 1985. Genea Stem Cells Pty ...

Genea Stem Cells Pty Ltd

Genea Biocells Pty Ltd is a subsidiary of Genea Limited (formerly Sydney IVF Limited), a public, unlisted company that has been operating IVF clinics in Australia since 1985. Genea Biocells Pty Ltd ...

Cellectis Group

Cellectis stem cells, is a business unit within the Cellectis group and is a global leader in stem cell technology. Cellectis stem cells, created in November 2011 from Cellartis A...

Cellerant Therapeutics, Inc.

Embryonic Stem Cells are derived from early-stage embryos before mature organs and tissues have developed. Embryonic stem cells have the greatest potential for both self-renewal (creating large number...

Forever Labs

Forever Labs is the first company to bank young adult stem cells, so you can live a healthier and longer life. Research on stem cells suggest that as you age, you lose stem cells ...

More Information about "Genea Stem Cells Pty Ltd" on BioPortfolio

We have published hundreds of Genea Stem Cells Pty Ltd news stories on BioPortfolio along with dozens of Genea Stem Cells Pty Ltd Clinical Trials and PubMed Articles about Genea Stem Cells Pty Ltd for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Genea Stem Cells Pty Ltd Companies in our database. You can also find out about relevant Genea Stem Cells Pty Ltd Drugs and Medications on this site too.

Quick Search

Relevant Topics

Stem Cells
Track and monitor developments in stem cell research and commercial development.  Follow the tabs above to read the latest global news, research, clinical trials on stem cells and follow companies active in the stem cell industry.  BioPort...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...


Corporate Database Quicklinks



Searches Linking to this Company Record